Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 14 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

29%

4 trials in Phase 3/4

Results Transparency

42%

5 of 12 completed with results

Key Signals

5 with results100% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (2)
P 1 (2)
P 2 (3)
P 3 (2)
P 4 (2)

Trial Status

Completed12
Unknown2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT00880698Phase 2Completed

Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers

NCT05032391Phase 3CompletedPrimary

Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization

NCT03207750Phase 3CompletedPrimary

This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine

NCT04626856Phase 1UnknownPrimary

Safety and Preliminary Immunogenicity Study of Inactivated Vaccine for Prevention of Rotavirus Infection

NCT02992197Phase 4CompletedPrimary

The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity

NCT01764256Phase 1CompletedPrimary

A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine

NCT01511133CompletedPrimary

Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™

NCT02662543UnknownPrimary

The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus Vaccines

NCT01266850Phase 4CompletedPrimary

Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules

NCT00895492Completed

Two-year Surveillance of Rotavirus Genotypes Causing Acute Diarrhea in Children Younger Than 5 Years Requiring Emergency Room (ER) and Hospital Admission in Chile

NCT00302640Phase 2CompletedPrimary

Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children

NCT01328925Phase 2CompletedPrimary

Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children

NCT00981877Not ApplicableCompleted

Probiotics in the Management of Acute Rotavirus Diarrhea in Bolivian Children

NCT00683982Not ApplicableCompleted

Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus

Showing all 14 trials

Research Network

Activity Timeline